马耳他 - 英文 - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - clozapine - tablet - clozapine 100 mg - psycholeptics

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - clozapine, quantity: 200 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; povidone; purified talc; colloidal anhydrous silica; magnesium stearate

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - clozapine, quantity: 100 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; povidone; purified talc; colloidal anhydrous silica; magnesium stearate

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - clozapine, quantity: 50 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; povidone; purified talc; colloidal anhydrous silica; magnesium stearate

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - clozapine, quantity: 25 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; povidone; purified talc; colloidal anhydrous silica; magnesium stearate

加拿大 - 英文 - Health Canada

pharmascience inc - clozapine - tablet - 25mg - clozapine 25mg - atypical antipsychotics

加拿大 - 英文 - Health Canada

pharmascience inc - clozapine - tablet - 100mg - clozapine 100mg - atypical antipsychotics

加拿大 - 英文 - Health Canada

sandoz canada incorporated - clozapine - tablet - 25mg - clozapine 25mg - atypical antipsychotics

加拿大 - 英文 - Health Canada

sandoz canada incorporated - clozapine - tablet - 100mg - clozapine 100mg - atypical antipsychotics

美国 - 英文 - NLM (National Library of Medicine)

tya pharmaceuticals - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 25 mg - clozaril is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. because of the significant risk of agranulocytosis and seizure associated with its use, clozaril should be used only in patients who have failed to respond adequately to standard antipsychotic treatment . [see warnings and precautions (5.1, 5.4)] the effectiveness of clozaril in treatment-resistant schizophrenia was demonstrated in a 6-week, randomized, double-blind, active-controlled study comparing clozaril and chlorpromazine in patients who had failed other antipsychotics . [see clinical studies (14.1)] clozaril is indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to action